The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/35850
StudyName: Eligibility EGFR Mutated EGFR TKI Naïve Metastatic NSCLC NCT02206763
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 27.03.2019
License: Creative Commons BY 4.0

----

Description: 
Erlotinib and Momelotinib for the Treatment of Epidermal Growth Factor Receptor (EGFR) Mutated EGFR Tyrosine Kinase Inhibitor (TKI) Naive Metastatic Non-Small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT02206763
